Cargando…
Adding pharmacogenomics to the development of new marine-derived anticancer agents
Nature has always been a highly productive tool in the development of anticancer therapies. Renewed interest in the potential of this tool has recently been sparked by the realization that the marine ecosystem can be used for the discovery and development of new compounds with clinical potential in...
Autores principales: | Jimeno, José, Aracil, Miguel, Tercero, Juan Carlos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1334219/ https://www.ncbi.nlm.nih.gov/pubmed/16401350 http://dx.doi.org/10.1186/1479-5876-4-3 |
Ejemplares similares
-
Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets
por: Pereira, Renato B., et al.
Publicado: (2019) -
New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials
por: Jimeno, J., et al.
Publicado: (2004) -
Can Some Marine-Derived Fungal Metabolites Become Actual Anticancer Agents?
por: Gomes, Nelson G. M., et al.
Publicado: (2015) -
Marine Mollusk‐Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance
por: Ciavatta, Maria Letizia, et al.
Publicado: (2016) -
Novel Marine Secondary Metabolites Worthy of Development as Anticancer Agents: A Review
por: Mbaoji, Florence Nwakaego, et al.
Publicado: (2021)